Suboptimal Treatment of Diabetic Peripheral Neuropathic Pain in the United States

Pain Medicine (United States)

Volumn 16, Issue 11, 2015, Pages 2075-2083

  Yang, Mei ^a   Qian, Chunlin ^a   Liu, Yifei ^b  

^a DAIICHI SANKYO INC   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

Adherence; Claims database; Diabetic peripheral neuropathic pain; Discontinuation; Dose; Treatment

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; DESIPRAMINE; DULOXETINE; GABAPENTIN; LIDOCAINE; MORPHINE; NORTRIPTYLINE; OPIATE; OXYCODONE; PREGABALIN; TRAMADOL; VENLAFAXINE; 4 AMINOBUTYRIC ACID; AMINE; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE;

ADULT; AGED; ANALGESIA; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DIABETIC NEUROPATHY; DIABETIC PERIPHERAL NEUROPATHIC PAIN; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MONOTHERAPY; OFF LABEL DRUG USE; PATIENT COMPLIANCE; PATIENT SATISFACTION; PERIPHERAL NEUROPATHY; PRESCRIPTION; RETROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT OUTCOME; UNITED STATES; DIABETIC NEUROPATHIES; MIDDLE AGED; NEURALGIA; QUALITY OF LIFE;

ADULT; AGED; AMINES; ANTIDEPRESSIVE AGENTS; CYCLOHEXANECARBOXYLIC ACIDS; DIABETIC NEUROPATHIES; DULOXETINE HYDROCHLORIDE; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIDDLE AGED; NEURALGIA; PREGABALIN; QUALITY OF LIFE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; UNITED STATES;

EID: 84955195715     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/pme.12845     Document Type: Article

References (39)

1. Tesfaye S, Selvarajah D. Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy. Diabetes Metab Res Rev 2012;28:8-14.
2. Iyer S, Tanenberg RJ. Pharmacologic management of diabetic peripheral neuropathic pain. Expert Opin Pharmacother 2013;14:1765-75.
3. Sadosky A, McDermott AM, Brandenburg NA, Strauss M. A review of the epidemiology of painful diabetic peripheral neuropathy, postherpetic neuralgia, and less commonly studied neuropathic pain conditions. Pain Pract 2008;8:45-56.
4. Kuritzky L. Managing diabetic peripheral neuropathic pain in primary care. J Fam Pract 2010;59:S15-22.
5. van Hecke O, Austin SK, Khan RA, Smith BH, Torrance N. Neuropathic pain in the general population: A systematic review of epidemiological studies. Pain 2014;155:654-62.
6. Dieleman JP, Kerklaan J, Huygen FJ, Bouma PA, Sturkenboom MC. Incidence rates and treatment of neuropathic pain conditions in the general population. Pain 2008;137:681-8.
7. Dulipsingh L, Zailskas S, Goldsby T, McInnis T, Marotta A. Assessment of pain and treatment satisfaction in patients with painful diabetic peripheral neuropathy. Conn Med 2013;77:523-7.
8. Deli G, Bosnyak E, Pusch G, Komoly S, Feher G. Diabetic neuropathies: Diagnosis and management. Neuroendocrinology 2013;98:267-80.
9. Cole BE. Diabetic peripheral neuropathic pain: Recognition and management. Pain Med 2007;8:S27-32.
10. daCosta DiBonaventura M, Cappelleri JC, Joshi AV. A longitudinal assessment of painful diabetic peripheral neuropathy on health status, productivity, and health care utilization and cost. Pain Med 2011;12:118-26.
11. Barrett AM, Lucero MA, Le T, et al. Epidemiology, public health burden, and treatment of diabetic peripheral neuropathic pain: A review. Pain Med 2007;8:S50-62.
12. Khalil H. Painful diabetic neuropathy management. Int J Evid Based Healthc 2013;11:77-9.
13. Bril V, England, JD, Franklin GM, et al. Evidence-based guideline: Treatment of painful diabetic neuropathy-report of the American Association of Neuromuscular and Electrodiagnostic Medicine, the American Academy of Neurology, and the American Academy of Physical Medicine & Rehabilitation. Muscle Nerve 2011;43:910-7.
14. Spallone V. Management of painful diabetic neuropathy: Guideline guidance or jungle? Curr Diabetes Rep 2012;12:403-13.
15. LYRICA (Pregabalin) Capsules, CV LYRICA (Pregabalin) Oral Solution [package insert]. New York, NY: Pfizer Pharmaceuticals; 2013.
16. CYMBALTA (Duloxetine Delayed-Release Capsules) for Oral Use [package insert]. Indianapolis, IN: Lilly USA LLC; 2012.
17. NUCYNTA ER (tapentadol) Extended-Release Oral Tablets [package insert]. Titusville, NJ: Janssen Pharmaceuticals, Inc.; 2013.
18. Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2009 revision. Eur J Neurol 2010;17:1113-e88.
19. Lindsay TJ, Rodgers BC, Savath V, Hettinger K. Treating diabetic peripheral neuropathic pain. Am Fam Physician 2010;82:151-8.
20. Freeman R. New and developing drugs for the treatment of neuropathic pain in diabetes. Curr Diabetes Rep 2013;13:500-8.
21. Lunn MP, Hughes RA, Wiffen PJ. Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database Syst Rev 2014;1:CD007115
22. Moore RA, Wiffen PJ, Derry S, McQuay HJ. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev 2011;3:CD007938
23. Ormseth MJ, Scholz BA, Boomershine CS. Duloxetine in the management of diabetic peripheral neuropathic pain. Patient Prefer Adherence 2011;5:343-56.
24. Chen SY, Wu N, Boulanger L, Fraser KA, Zhao Y. The relationship between average daily dose, medication adherence, and health-care costs among diabetic peripheral neuropathic pain patients initiated on duloxetine therapy. Pain Pract 2010;10:530-9.
25. Sun P, Zhao Y, Zhao Z, Bernauer M, Watson P. Dosing pattern comparison between duloxetine and pregabalin among patients with diabetic peripheral neuropathic pain. Pain Pract 2012;12:641-8.
26. Zhao Y, Sun P, Watson P. Medication adherence and healthcare costs among patients with diabetic peripheral neuropathic pain initiating duloxetine versus pregabalin. Curr Med Res Opin 2011;27:785-92.
27. Gore M, Zlateva G, Tai KS, Chandran AB, Leslie D. Retrospective evaluation of clinical characteristics, pharmacotherapy and healthcare resource use among patients prescribed pregabalin or duloxetine for diabetic peripheral neuropathy in usual care. Pain Pract 2011;11:167-79.
28. Quan H, Li, B, Couris CM, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol 2011;173:676-82.
29. Peterson AM, Nau DP, Cramer JA, et al. A checklist for medication compliance and persistence studies using retrospective databases. Value Health 2007;10:3-12.
30. Neurontin (Gabapentin) Capsules, Neurontin (Gabapentin) Tablets, Neurontin (Gabapentin) Oral Solution [package insert]. New York, NY: Parke-Davis; 2014.
31. Lesser H, Sharma U, LaMoreaux L, Poole RM. Pregabalin relieves symptoms of painful diabetic neuropathy: A randomized controlled trial. Neurology 2004;63:2104-10.
32. Richter RW, Portenoy R, Sharma U, et al. Relief of painful diabetic peripheral neuropathy with pregabalin: A randomized, placebo-controlled trial. J Pain 2005;6:253-60.
33. Skljarevski V, Frakes EP, Sagman D, et al. Review of efficacy and safety of duloxetine 40 to 60 mg once daily in patients with diabetic peripheral neuropathic pain. Pain Res Treat 2012;2012:898347
34. O'Connor AB. Neuropathic pain: Quality-of-life impact, costs and cost effectiveness of therapy. PharmacoEconomics 2009;27:95-112.
35. Robinson-Papp J, Simpson DM. Safety profile of treatment in diabetic peripheral neuropathic pain. Pain Med 2007;8:S43-9.
36. Boyle J, Eriksson ME, Gribble L, et al. Randomized, placebo-controlled comparison of amitriptyline, duloxetine, and pregabalin in patients with chronic diabetic peripheral neuropathic pain: Impact on pain, polysomnographic sleep, daytime functioning, and quality of life. Diabetes Care 2012;35:2451-8.
37. Quilici S, Chancellor, J, Lothgren M, et al. Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain. BMC Neurol 2009;9:6.
38. Happich M, Schneider, E, Boess FG, et al. Effectiveness of duloxetine compared to pregabalin and gabapentin in diabetic peripheral neuropathic pain: Results from a German observational study. Clin J Pain 2014;30:875-85.
39. US National Institutes of Health. Clinicaltrials.gov Web site. Available at: http://www.clinicaltrials.gov. Accessed July 29, 2014.